arrow
S

Sabine Brookman-May

aura biosciences
H指数:31
被引数:4,179

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non–muscle-invasive Bladder Cancer

Bel-sar在间质风险和高度风险非肌层浸润性膀胱癌患者中的早期疗效和探索性生物标志物数据

2026-06-130
OAAI
Efficacy of a Modular App-Based Pelvic Floor Muscle Training Program for Postoperative Continence Recovery After Radical Prostatectomy: A Multi-Center Randomized Controlled Trial (PELVINTENSE Study)

基于模块化应用程序的盆底肌肉训练计划对根治性前列腺切除术后术后控尿恢复的疗效:一项多中心随机对照试验(PELVINTENSE研究)

Cancers
IF4.4
2026-04-230
OA
Benchmarking Large Language Models Against Multidisciplinary Tumor Boards in Urological Oncology: Results from the Blinded, Prospective CONCORDIA Study

评估大型语言模型与泌尿肿瘤学多学科肿瘤委员会的比较:来自盲法、前瞻性CONCORDIA研究的结果

2025-12-110
PRE
Influential Factors Impacting Treatment Decision-making and Decision Regret in Patients with Localized or Locally Advanced Prostate Cancer: A Systematic Literature Review

影响局部或局部晚期前列腺癌患者治疗决策和决策后悔的影响因素: 系统文献综述

2024-12-010
OA
Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate Cancer

SPARTAN和TITAN晚期前列腺癌患者快速和深度前列腺特异性抗原下降和患者报告的健康相关生活质量的事后分析

2024-08-015
PRE
Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapy
2024-06-286
OA
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective Study
2024-06-012
OA